Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pQC NLS YFP IX Citations (3)

Originally described in: Conditional expression of the TVA receptor allows clonal analysis of descendents from Cre-expressing progenitor cells.
Beier KT, Samson ME, Matsuda T, Cepko CL Dev Biol. 2011 May 15;353(2):309-20. Epub 2011 Mar 21.
PubMed Journal

Articles Citing pQC NLS YFP IX

IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy. Jacob Berger A, Gigi E, Kupershmidt L, Meir Z, Gavert N, Zwang Y, Prior A, Gilad S, Harush U, Haviv I, Stemmer SM, Blum G, Merquiol E, Mardamshina M, Kaminski Strauss S, Friedlander G, Bar J, Kamer I, Reizel Y, Geiger T, Pilpel Y, Levin Y, Tanay A, Barzel B, Reuveni H, Straussman R. Nat Cancer. 2021 Oct;2(10):1055-1070. doi: 10.1038/s43018-021-00261-1. Epub 2021 Oct 21. PubMed
Evaluation of a gain-managed nonlinear fiber amplifier for multiphoton microscopy. Sidorenko P, Buttolph M, Mejooli M, Eom CY, Schaffer CB, Wise F. Biomed Opt Express. 2023 Apr 26;14(5):2324-2332. doi: 10.1364/BOE.485226. eCollection 2023 May 1. PubMed
ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei. Joo YK, Black EM, Trier I, Haakma W, Zou L, Kabeche L. Mol Cell. 2023 Oct 19;83(20):3642-3658.e4. doi: 10.1016/j.molcel.2023.09.003. Epub 2023 Oct 2. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.